Fluoro-substituted flavones and 2-styrylchromones, related to natural and synthetic flavonoids previously described, were prepared, characterized and tested for anti-rhinovirus activity. Structural elucidation of the new compounds was performed by IR, NMR spectra and X-ray crystal structure analysis for 6-fluoro-3-hydroxy-2-styrylchromone. The antiviral potency was evaluated by a plaque reduction assay in HeLa cell cultures infected with rhinoviruses 1B and 14, selected as representative serotypes for viral groups B and A of human rhinoviruses, respectively. In comparison with results previously obtained, the introduction of the fluorine atom seems to exert a positive influence on the activity against serotype 14 while counteracting the effect against serotype 1B.
Introduction
Human rhinoviruses (HRVs), members of the picornavirus family, are small single-stranded RNA viruses. There are over 100 serotypes of HRVs and they are the most frequent cause of the common cold and probably the most usual aetiological agents of acute illness that are associated with restricted activity. Although these infections are often mild and self-limiting in healthy adults, they can exacerbate several chronic conditions such as asthma, sinusitis and emphysema; moreover, serious sequelae can occur in children (Greenberg, 2003) .
The widespread nature of the diseases associated with rhinoviruses, their economic and medical importance and the difficulty of vaccine development due to the existence of multiple serotypes, has stimulated the search for effective chemotherapeutic agents. However, despite the in vitro activity of different chemical classes of compounds, only a few of these inhibitors have shown effectiveness in humans without significant adverse effects (Shih et al., 2004) .
The anti-picornavirus activity of several synthetic and natural flavonoids and flavanoids was found to be particularly interesting. Flavonoids and flavanoids are important groups of oxygenated heterocycles widespread in the plant kingdom and consumed daily in the human diet. They contribute to the colour of many flowers and vegetables and are involved in the defensive system of plants (Hodek et al., 2002) . In addition, several medicinal plants and herbs used in folk medicine contain flavanoids and flavonoids ( Jassim & Naji, 2003) . Natural compounds, together with a number of synthetic analogues, are responsible for a great variety of biological and pharmacological activities, including antipicornavirus properties (Shih et al., 2004; Hodek et al., 2002; Jassim & Naji, 2003) .
Previous studies on natural flavones (2-phenylchromones) have shown that the presence of a 3-methoxy group is an important requirement for potent antipicornavirus activity (Van Hoof et al., 1984; Tsuchiya et al., 1985) . Further research has confirmed the correlation between the substituent in position 3 and the antipicornavirus potency of both natural and synthetic flavones (De Meyer et al., 1991; Desideri et al., 1995; Conti et al., 1998; Semple et al., 1999) .
Recently, we synthesized a series of 2-styrylchromones (one of the scarcest classes of natural flavonoids) as vinylogues of flavones, in order to assess whether the replacement of the 2-phenyl substituent on the chromone ring by 2-styryl would affect the antiviral properties (Desideri et al., 2000) . In addition, the influence of the substituent in position 3 was also evaluated for this class of flavonoids (Desideri et al., 2003) (Figure 1 ). Antiviral results indicated that 2-styrylchromones can be considered as a new class of anti-rhinovirus flavonoids with activity against both rhinovirus groups A and B (Desideri et al., 2000 (Desideri et al., , 2003 .
The two groups of HRVs were identified by the different susceptibility of all serotypes to a panel of anti-rhinovirus compounds. Group B contains twice as many serotypes as group A and accounts for five times as many clinical infections as group A (Andries et al., 1990 (Andries et al., , 1991 . As expected, the introduction of a 3-hydroxy or a 3-methoxy group also improves the anti-rhinovirus activity of 2-styrylchromones (Desideri et al., 2003) .
While naturally occurring flavonoids are characterized by the presence of multiple hydroxy and methoxy groups substituting the basic flavonoid skeleton, their synthetic analogues are preferentially substituted with methyl, chloro, nitro, amino and carboxy groups, as well as hydroxy and methoxy groups (De Meyer et al., 1991; Desideri et al., 1995 Desideri et al., , 1997 Desideri et al., , 2000 Desideri et al., , 2003 Conti et al., 1998) . The unusual substituents for naturally occurring flavonoids were introduced in order to investigate their influence on activity. Although the greatest potency was achieved with the introduction of strong electron-withdrawing groups, to the best of our knowledge, only one fluoroflavone has been tested for its anti-picornavirus activity (De Meyer et al., 1991) .
Therefore, we designed, synthesized and tested a series of fluoro-substituted flavonoids related to the most active natural and synthetic flavonoids previously described, with the aim to study (i) the impact of the introduction of a strong electronegative fluorine atom on the A ring, (ii) the influence of the replacement on the chromone moiety of the 2-phenyl by the 2-styryl substituent and (iii) the requirement of a 3-hydroxy or 3-methoxy group in the 3 position of the chromone ring.
Materials and methods

Chemistry
Melting points were determined on a Büchi SMP-20 apparatus (Buchi, Flawil, Switzerland) (Levai et al., 2001) . . Anhydrous K 2 CO 3 (10 g) was added to a mixture of 5′-fluoro-2′-hydroxyacetophenone (10 mmol) and cinnomoyl chloride (10 mmol) in dry acetone (100 ml) and the mixture was refluxed for 18 h with stirring. After cooling, the solid was filtered off, washed with acetone and the filtrate was evaporated to dryness. The residue was suspended in dilute hydrochloric acid (2N) 
1-
General procedure for the synthesis of 6-fluoro-3-
hydroxychromen-4-ones [6,7]. Hydrogen peroxide (4 ml, 35%) was added to a mixture of (5-fluoro-2-hydroxyphenyl)-
(10 mmol) in methanol (70 ml) and dilute sodium hydroxide (35 ml, 5%) and cooled in an ice bath. The solution was stirred for 5 h at 0-5°C and then for 16 h at room temperature. The reaction mixture was poured into ice water and acidified with dilute hydrochloric acid (6N). The precipitate was collected by filtration, washed with water and crystallized. (10 mmol) were suspended in dry acetone (600 ml), then dry potassium carbonate (60 mmol) and dimethyl sulphate (20 mmol) were added. The mixture was refluxed for 20 h with stirring. After cooling, the acetone was evaporated under reduced pressure and water was added to the residue. The precipitate was collected by filtration, washed with water and crystallized. 
6-Fluoroflavone [10]
. Selenium (IV) oxide (17.5 mmol) was added to a solution of 1-(5-fluoro-2-hydroxyphenyl)-3-phenylpropen-1-one [4] (10 mmol) in dimethyl sulphoxide (70 ml). The mixture was heated at 130°C for 2.5 h with stirring. After cooling, the mixture was filtered and the filtrate was poured into ice water. The precipitate was collected by filtration, washed with water and crystallized from AcOEt. Yield 81%, m.p. 130-131°C [lit. m.p. 128-129°C (Chang et al., 1961) ]; IR (KBr) 1660/cm; 1 H NMR (CDCl 3 ) δ 7.94-7.90 (m, 2H, H2′, H6′), 7.87 (dd, 1H, H5, J 5-F =8.1 Hz, J 5-7 =3.1Hz), 7.59 (dd, 1H, H8, J 7-8 =9.1 Hz, J 8-F =4.1 Hz), 7.57-7.51 (m, 3H, H3′-5′), 7.43 (m, 1H, H7, J 7-8 =9.1 Hz, J 7-F =7.6 Hz, J 5-7 =3.1 Hz), 6.82 (s, 1H, H3).
6-Fluoroflavanone [11].
A mixture of 1-(5-fluoro-2-hydroxyphenyl)-3-phenylpropen-1-one [4] (10 mmol) in concentrated hydrochloric acid (15 ml) and concentrated acetic acid (130 ml) was heated at 120°C for 17 h with stirring. After cooling, the mixture was poured into ice water and the precipitate was filtered, washed with water and crystallized from petroleum ether. Yield 87%, m.p. 73-76°C EtOH [lit. m.p. 77-78°C (Chang et al., 1961) ]; IR (KBr) 1690/cm; Rimsting, Germany) (Colapietro et al., 1992) with graphite monochromatized Mo-Kα radiation (λ=0.71069 A). A total of 9844 reflections were collected at room temperature up to θ=25.00°using ω-scan. Three standard reflections measured after every 97 reflections showed no appreciable decay. All intensities were corrected for Lorentz and polarization effects, but not for absorption. The structure was solved by direct methods and refined by full-matrix leastsquares on F 2 . All the hydrogen atoms were clearly located through a Fourier synthesis and introduced into the final full-matrix least-squares refinement in a riding model with the isotropic temperature factors arbitrarily fixed. (Altomare et al., 1999) , SHELXL (Sheldrick, 1997) and ORTEP-3 (Farrugia, 1997) packages. Atomic form factors were taken from International Tables for X-Ray Crystallography (Ibers & Hamilton, 1974) .
Virology Cells
HeLa (Ohio) cells were routinely grown at 37°C using Eagles MEM supplemented with 100µg/ml of streptomycin and 100 U/ml of penicillin G and 8% heat-inactivated fetal calf serum (FCS) (growth medium). The concentration was reduced to 2% for cell maintenance (maintenance medium).
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Virus
Reference strains of HRV type 1B and 14 were purchased from the American Type Culture Collection. Virus stocks were prepared by inoculating HeLa (Ohio) cell monolayers at a low multiplicity of infection (0.1 PFU/cell). Infected cells were incubated at 33°C. When the viral-induced cytopathic effect involved most of the cells, the cultures were freeze-thawed three times and the clarified supernatants titred by plaque assay, essentially as described by Fiala & Kenny (1966) . The virus was stored in aliquots at -80°C until used.
XTT assay for cellular cytotoxicity
A tetrazolium-based (XTT) colorimetric assay was used to measure the cytotoxicity of the compounds. This assay is based on the cleavage of the yellow tetrazolium salt XTT to form an orange formazan dye by viable, active cells. The formazan dye formed is soluble in aqueous solution and is directly quantified using a scanning multiwell spectrophotometer (Scudiero et al., 1988) . HeLa cells were seeded in 96-well tissue culture plates at 2×10 3 cells per well in 100 µl of growth medium with or without compounds in twofold dilutions, starting from the maximum soluble concentration in cell culture medium. Quadruplicate wells were used for each drug concentration to be tested. The plates were incubated at 37°C in 5% CO 2 -air until the untreated monolayers were confluent (3 days). Next, 50 µl of XTT-labelling mixture was added to each well (final XTT concentration 0.15 mg/ml) and the cells incubated for 4 h at 37°C. The spectrophotometric absorbance of the samples was measured using an ELISA reader at 492 nm with a reference wavelength at 690 nm. Cytotoxicity was also scored microscopically as morphological alterations on the third day of incubation in the presence of compounds. The highest concentration of compound that did not produce any modification of morphology and viability on 100% of cells was the maximum non-cytotoxic concentration (MNCC). The 50% cytotoxic concentration (CC 50 ) was indicated as the concentration of compound reducing the cell viability by 50%, as compared with mocktreated cells.
Determination of the 50% inhibitory concentration (IC 50 )
The IC 50 values were determined as previously described (Desideri et al., 1992) . Briefly, confluent monolayers of HeLa cells in six-well plates were infected with a virus suspension producing approximately 100 plaques per well.
After 1 h of incubation at 33°C, the virus inoculum was removed and the cells were overlaid with medium for plaques, in the presence or absence of fourfold dilutions of drugs. After 3 days of incubation at 33°C, the cells were stained with a neutral red solution at 0.2 mg/ml in pH 7.4 PBS and the plaques were counted. The IC 50 was expressed as the concentration of drug reducing the plaque number by 50% as compared with mock-treated control. It was calculated from a dose-response curve obtained by plotting the percentage of plaque reduction, with respect to the control plaque count, versus the logarithm of compound dose. Triplicate wells were utilized for each drug concentration.
Results
Chemistry 6-Fluoro-2-styrylchromone [3] was conveniently prepared according to the two-step modified Baker-Venkataraman method (Reddy & Krupadanam, 1996) (Figure 2 ). For this purpose, an acetone solution of 5′-fluoro-2′-hydroxyacetophenone and cinnamoyl chloride was refluxed in the presence of potassium carbonate to give the 1,3-diketone [1] involved in keto-enolic equilibrium. As previously reported for analogous compounds (Desideri et al., 2000; Reddy & Krupadanam, 1996; Pinto et al., 1998) , spectral data allow confirmation that it exists exclusively in the tautomeric enolic form [2], both in the solid state and in chloroform solution. In fact, the IR spectrum (KBr) presents only one carbonyl peak, shifted to 1635/cm by the strong intramolecular hydrogen bonding. In the 1 H NMR spectrum (chloroform-d), the enolic hydroxy group appears at 14.61 ppm while the phenolic hydroxyl appears at 11.97 ppm. Moreover, the diene structure is confirmed by the presence of three signals, each for one olefinic proton: a pair of doublets at 7.68 and 6.60 ppm for H5 and H4, respectively, and a singlet at 6.22 ppm for H2. The high value of the coupling constant ( J 4-5 =15.8 Hz) confirms the trans configuration of this double bond.
The cyclodehydration of 3-hydroxy-2,4-pentadien-1-one [2] into desired 6-fluoro-2-styrylchromone [3] was obtained by heating in ethanolic sulphuric acid (Figure 2) . The trans configuration of the vinylic double bond was indicated by the coupling constant value ( J α-β =16.1 Hz) in the 1 H NMR spectrum. However, the conformation of C2-Cα bond was also considered, due to the high degree of conjugation in the dienone portion of molecule. The intense cross peak between H3 and Hα observed in two-dimensional NOESY experiments demonstrated the s-cis conformation as shown in Figure 2 . These results agree with previous studies indicating a (s-cis)-trans geometry for analogue 2-styrylchromones (Pinto et al., , 2000 Silva et al., 1998 Silva et al., , 2002 .
As shown in Figure 3 The stereochemistry of the 3-substituted 2-styrylchromones ([7] and [9]) was also investigated. In the 1 H NMR spectra, the coupling constant values ( J α-β about 16 Hz) confirm the trans configuration of the vinylic group also in the 3-hydroxy-and 3-methoxy-2-styrylchromones ([7] and [9]). Moreover, further experiments were necessary to elucidate the conformation of the styryl moiety relative to the chromone ring. In the case of 3-methoxy-2-styrylchromone [9], the strong cross peak between OCH 3 and Hα observed in two-dimensional NOESY experiments demonstrated the s-cis conformation of the C2-Cα bond. However, the NOESY experiments carried out with 3-hydroxy-2-styrylchromone [7] did not allow us to establish its conformation, probably due to the rapid exchange of a hydroxylic proton. Therefore, the assignment of the stereochemistry of this compound was based on X-ray crystal structure analysis.
The chalcone 
Crystal structure determination
The crystal structure of 6-fluoro-3-hydroxy-2-styrylchromone [7] consists of planar molecules in which the carbon-carbon double bond of the vinylic group is in trans configuration and the styryl moiety relative to the chromone nucleus is in s-cis conformation ( Figure 5 ). The molecular geometry of the chromone moiety shows no special features. Concerning the phenyl group, the sensitivity of the molecular geometry to the nature of the substituents has been established for a large number of benzenoid rings (Domenicano & Hargittai, 1992) . The decrease of the ipso angle [118.4 (3)°] is definitely real, and caused by the replacement of the H atom by the CHR=CH-moiety.
In the crystal of the chromone derivative, the centrosymmetric dimers form the well-known R 2 2 (10) synthons (Etter et al., 1990) 
Antiviral activity
All synthesized flavonoids were tested in vitro against HRV serotypes 1B and 14 belonging to viral group B and A, respectively (Andries et al., 1990 (Andries et al., , 1991 . The existence of two rhinovirus groups with different sensibility to antirhinovirus compounds suggests selecting one serotype from each group to identify broad-spectrum anti-rhinoviruses. 4′,6-Dichloroflavan [BW683C] (Bauer et al., 1981) , an inhibitor of group B serotypes, was included as a control (Figure 6 ). In preliminary studies, the cytotoxicity of all compounds was evaluated by measuring the effect on morphology, viability and growth of HeLa (Ohio) cells, a human cell line suitable for the replication of HRVs. Morphological alterations were scored microscopically, and the effect of the compounds on logarithmic cell growth was determined by the XTT colorimetric method (Scudiero et al., 1988) . Table 2 reports the maximum non-cytotoxic concentrations (MNCCs) and the 50% cytotoxic concentrations (CC 50 s) of compounds [2-11]. The MNCC was expressed as the highest dose tested that did not produce any cytotoxic effect or reduction on cell growth, after 3 days of incubation at 37°C. The CC 50 was indicated as the concentration of compound reducing the cell viability by 50%, as compared with the control. 3-Hydroxy-2,4-pentadien-1-one [2] showed the highest cytotoxicity (MNCC=3.12 µM and CC 50 =6.25 µM). The removal of the 3-hydroxy group on the chain led to the less toxic 2,4-pentadien-1-one [5] (MNCC=25.00 µM and CC 50 =100.00 µM). The CC 50 s of the other compounds ranged from 25.00-100.00 µM.
The inhibitory activity of the compounds on HRV replication was evaluated in a plaque reduction assay, starting from the MNCC. The compound concentration required to produce a 50% reduction of plaque number with respect to mock-treated virus-infected cultures (IC 50 ) was calculated by dose-response plots using the linear regression technique. When the IC 50 value was higher than the MNCC, the percentage inhibition at this dose was reported in parentheses (Table 2 ). In addition to an effect on plaque number, the tested compounds caused a reduction in viral plaque size (from 70 to 50%) of both HRV serotypes, suggesting a slowing down of the kinetics of viral replication and/or a neutralizing action on progeny virus. The data of antiviral assays indicated that HRV serotypes 1B and 14 exhibited a different sensitivity to the compounds.
Discussion
In this study, we describe the synthesis and the activity against HRV serotypes 1B and 14 of a series of fluorosubstituted flavones and 2-styrylchromones related to flavonoids previously described. All the tested flavonoids interfered with the replication of HRV serotype 14, although with moderate potency, while compounds (Bauer et al., 1981; Conti et al., 1998; Desideri et al., 1997 Desideri et al., , 2000 Desideri et al., , 2003 . Generally, group B of HRVs are inhibited by shortchain compounds (chalcones, flavonoids, flavanoids) whereas group A by elongated molecules (R 61837 and WIN compounds) (Andries et al., 1990 (Andries et al., , 1991 Shih et al., 2004) . The most considerable difference between previously reported flavonoids and new synthesized fluoroflavonoids is the presence of a fluorine atom on the A ring, suggesting that this substituent exerts a positive influence on activity against serotype 14 while counteracting the effect against serotype 1B.
Among halo-substituted flavans (2-phenylchromanes) described by Bauer (1981) , 4′,6-dichloroflavan [BW683C] exhibited the most potent antiviral activity against HRV serotype 1B and a selectivity against group B of HRVs (Bauer et al., 1981; Andries et al., 1990 Andries et al., , 1991 . When compared with corresponding chloroflavans, 4′,6-difluoroflavan and 6-fluoroflavan showed a reduction in potency against serotype 1B of 10-and threefold, respectively (Bauer et al., 1981) . Unfortunately, the lack of data on inhibition of other HRV serotypes limits our knowledge of the anti-rhinovirus spectrum of fluoro-substituted flavans.
In the series of fluoro-substituted flavonoids that we have synthesized, the replacement on the chromone moiety of the 2-phenyl substituent (flavones ) did not appear to contribute significantly to anti-rhinovirus 14 activity, whereas this modification generally opposed the activity against serotype 1B.
For synthetic flavones and 2-styrylchromones, a positive correlation between anti-rhinovirus activity and the presence of a hydroxy or a methoxy group in the 3 position of the chromone ring has been previously reported (Desideri et al., 1995 (Desideri et al., , 2003 . Among the new tested (Desideri et al., 2001) . All the previously studied 3-unsubstituted 2-styrylchromones interfered with HRV 1B replication while only some of them inhibited serotype 14. In particular, 2-styrylchromone and 6-chloro-2-styrylchromone showed a higher potency than the corresponding 6-fluoro-2-styrylchromone [3] against HRV serotype 1B (IC 50 =6.19 µM and 9.27 µM, respectively) while exhibiting a weak inhibition or inactivity against serotype 14 (Desideri et al., 2001) . The introduction of a 3-hydroxy or a 3-methoxy substituent ([7] and [9]) enhanced the activity of 6-fluoro-2-styrylchromone [3] against serotypes 14 and led to the loss of efficacy against HRV 1B. The specific activity against serotype 14 of 2-styrylchromones [7] and [9] can be ascribed to the presence of a fluorine atom in position 6. In fact, all the previously studied 3-hydroxy-and 3-methoxy-2-styrylchromones, unsubstituted or with a chlorine atom in the 6 position, interfered with the replication of HRV 1B, with IC 50 s ranging from 0.94-10.29 µM. Moreover, they exhibited a variable degree of activity or were ineffective against serotype 14 (Desideri et al., 2003) .
In conclusion, although the new compounds did not result in any highly potent anti-rhinovirus agents, the antiviral data indicate the positive influence of a fluorine atom on activity against serotype 14. Considering the preferential effect against group B serotypes of previously studied flavonoids acting as capsid binders and inhibitors of viral uncoating, it could be interesting to clarify the mechanism of action of fluorinated derivatives toward HRV14.
Supplementary material
Crystallographic data (excluding structure factors) for the structures reported in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publications number 244646. Copies of the data can be obtained free of charge on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; (fax: +44 1 223 336033; E-mail: deposit@ccdc.cam.ac; www.ccdc.cam.ac.uk/ conts/retrieving.html) Compound producing a reduction (from 70 to 50%) in the mean viral plaque size, besides an effect on plaque number.
#
Not measurable (the saturation concentration in cell culture medium was found to be lower than CC 50 ). MNCC, maximum non-cytoxic concentration.
